Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2016 (2016), Article ID 4131403, 9 pages
http://dx.doi.org/10.1155/2016/4131403
Research Article

Annexin A3 Knockdown Suppresses Lung Adenocarcinoma

1Department of Basic Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, China
2Laboratory Animal Center, Xiamen University, Xiamen, Fujian, China

Received 29 September 2016; Accepted 1 November 2016

Academic Editor: Giovanni Tuccari

Copyright © 2016 Ying-Fu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2006,” CA: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. G. Little, E. G. Gay, L. E. Gaspar, and A. K. Stewart, “National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care,” Lung Cancer, vol. 57, no. 3, pp. 253–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D.-S. Sun, L.-K. Hu, Y. Cai et al., “A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 3, pp. 1233–1239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Xu, D. Liu, H. Duan, Z. Guan, and Y. Han, “The expression and significance of annexin II in lung squamous cell cancer and adenocarcinom,” Chinese Journal of Lung Cancer, vol. 12, no. 5, pp. 375–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-F. Liu, Y.-H. Chen, M.-Y. Li et al., “Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma,” Medical Oncology, vol. 29, no. 1, pp. 174–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Gerke and S. E. Moss, “Annexins: from structure to function,” Physiological Reviews, vol. 82, no. 2, pp. 331–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Zeng, Z. Ke, Y. Song et al., “Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance,” Experimental and Molecular Pathology, vol. 95, no. 1, pp. 23–31, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Q.-Z. Pan, K. Pan, D.-S. Weng et al., “Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma,” Molecular Carcinogenesis, vol. 54, no. 8, pp. 598–607, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-Q. Xie, D. Fu, Z.-H. He, and Q.-D. Tan, “Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1α,” Oncology Letters, vol. 6, no. 6, pp. 1631–1635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Wu, S. Liu, C. Guo, Z. Hou, and M.-Z. Sun, “The role of annexin A3 playing in cancers,” Clinical and Translational Oncology, vol. 15, no. 2, pp. 106–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-M. Zhai, S.-J. Sun, W. Wang, and C. Zeng, “Expression of annexin A3 in gastric cancer and its correlation with proliferation and apoptosis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 7, pp. 3001–3004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. F. Liu, Z. Q. Xiao, M. X. Li et al., “Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma,” The Journal of Pathology, vol. 217, no. 1, pp. 54–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Bianchi, S. Bombelli, F. Raimondo et al., “Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of annexin A3,” American Journal of Pathology, vol. 176, no. 4, pp. 1660–1670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Q.-Z. Pan, K. Pan, Q.-J. Wang et al., “Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells,” STEM CELLS, vol. 33, no. 2, pp. 354–366, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Q.-Q. Liu, F.-F. Zhang, F. Wang et al., “TIPE2 inhibits lung cancer growth attributing to promotion of apoptosis by regulating some apoptotic molecules expression,” PLoS ONE, vol. 10, no. 5, Article ID e0126176, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-F. Liu, P.-F. Zhang, M.-Y. Li, Q.-Q. Li, and Z.-C. Chen, “Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma,” Clinical and Experimental Metastasis, vol. 28, no. 5, pp. 413–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Y. Yu, Y. Li, L. Q. Fan, Q. Zhao, B. B. Tan, and Y. Liu, “Impact of Annexin A3 expression in gastric cancer cells,” Neoplasma, vol. 61, no. 3, pp. 257–264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Q.-Z. Dong, Y. Wang, Z.-P. Tang et al., “Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9,” The American Journal of Pathology, vol. 182, no. 3, pp. 954–964, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Yan, W. Zhang, L.-Y. Jiang, W.-X. Qin, and X. Wang, “Reduced E-cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjects,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 11, pp. 4352–4356, 2014. View at Google Scholar · View at Scopus
  20. X. Qian, A. Anzovino, S. Kim et al., “N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties,” Oncogene, vol. 33, no. 26, pp. 3411–3421, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Gollob, S. Wilhelm, C. Carter, and S. L. Kelley, “Role of raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway,” Seminars in Oncology, vol. 33, no. 4, pp. 392–406, 2006. View at Publisher · View at Google Scholar · View at Scopus